You must be signed in to read the rest of this article.
Registration on CDEWorld is free. You may also login to CDEWorld with your DentalAegis.com account.
A new and powerful off-the-shelf bone and tissue regeneration technology termed Growth-Factor Enhanced Matrix has recently become available for clinical use. This graft material consists of a concentrated solution of pure recombinant human platelet-derived growth factor (rhPDGF-BB), the synthetic form of the body's key natural wound healing stimulator PDGF-BB, and an osteoconductive (bone scaffold) matrix. This if the first purified, recombinant (synthetic) growth factor product to be commercially available and is the result of over a decade of extensive research. Clinical and animal study results with this graft material demonstrate that it is capable of simultaneously promoting regeneration of bone and accelerating soft-tissue attach,ent gain in challenging periodontal and periimplant defects.
Registration on CDEWorld is free. You may also login to CDEWorld with your DentalAegis.com account.
The author reports no conflicts of interest associated with this work.
Queries for the author may be directed to justin.romano@broadcastmed.com.